The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
Voting is now open for the 2024 Company of the Year Awards
Aging digital systems limit the potential of decentralized trials. It's time to rethink the technologies driving them.
How the Drugs for Neglected Diseases Initiative and the Malaysian government partnered to tackle hep C with an affordable, effective cure.
How can we maximize the potential and production of potentially life-saving therapies?
When it comes to conducting clinical trials in emerging geographies, there are four key challenges to consider.
How can we ease the process of taking ATMPs to clinical trials? Two experts lay out the key considerations.
Can a new malaria vaccine hold the key to reliable, durable protection?
The lack of female representation in clinical trials impairs the very foundation that the development of safe and effective medicines is built upon.
As trials change and adapt, so too must clinical packaging.
How can advocacy groups help improve the clinical trials landscape?
We catch up with our Power Lister Rick Bright, to get his thoughts on the future of biopharma.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
Meet an AI Model that Predicts Teratogenicity
FDA Approves First OTC Contraceptive
Feeling the Heat